Linda Abetz-Webb from Adelphi Values (formerly named Mapi Values) writes for Pharmaphorum about how many treatments with potential value in children have not been tested in paediatric populations. Incentives and penalties to encourage paediatric research are in place, but measuring disease symptoms and impact in children and infants can… Read More